Co-morbid Hypertension and Diabetes and the Relationship to Parkinson’s Disease Motor Phenotype in the Nigeria Parkinson’s Disease Research Network Registry
Objective: To determine the frequency of hypertension (HBP) and type 2 diabetes mellitus (T2DM) as comorbidities in the Nigerian PD Research network (NPDR) cohort, and…Demographics of Botulinum toxin therapy population representative to demographics in Essex County, USA
Objective: To describe and compare the demographics of patients receiving botulinum toxin therapy in a single movement disorder clinic to the broader surrounding community. Background:…Plasma MicroRNA Expression Profiling in patients with Multiple System Atrophy and Parkinson’s Disease
Objective: Our objective was to identify differentially expressed, circulating miRNAs in Multiple System Atrophy-Parkinsonian type (MSA-P) and Parkinson’s disease (PD) which could serve as diagnostic…Pain types in multiple system atrophy: results from a community-based survey
Objective: To assess the frequency of different pain types in multiple system atrophy (MSA). Background: According to a recent meta-analysis, up to 60% of individuals…Heterogeneity of multiple system atrophy with an analysis of the clinical case
Objective: Multiple system atrophy (MSA) is a rapidly progressive neurodegenerative disease clinically characterized by various combinations of Parkinsonism with resistance to levodopa, cerebellar, autonomic, and…The Landscape of Interdisciplinary Care for Atypical Parkinsonism: A Qualitative Study from the CurePSP Centers of Care
Objective: To define interdisciplinary care practices for progressive supranuclear palsy (PSP), corticobasal syndrome (CBS), and multiple system atrophy (MSA). Background: PSP, CBS, and MSA are…Cytokine Profiles as Biomarkers for Neurodegenerative Diseases: An inflammatory study on Parkinson’s Disease and Tauopathies
Objective: To investigate the diagnostic and prognostic value of cytokine profiles in cerebrospinal fluid (CSF) and serum of patients with Parkinson's Disease (PD), Progressive Supranuclear…Plasma Biomarkers of Alzheimer’s Pathology Identify Prodromal Dementia with Lewy bodies
Objective: To determine whether plasma biomarkers of Alzheimer’s disease (AD) pathology can predict phenoconversion from idiopathic/isolated REM sleep behavior disorder (iRBD) to dementia with Lewy…Assessing the Accuracy of Clinical Diagnostic Criteria of Lewy Body Dementia for Detection of Lewy Body Disease in the Oldest-Old: The 90+ Study
Objective: To examine if Lewy Body dementia (LBD) clinical diagnostic criteria will be less accurate for detecting Lewy Body Disease (the pathological diagnosis) in the oldest-old…Age-associated presbyvestibulopathy is more severely abnormal in PD compared to the older controls
Objective: We aim to investigate differences in specific vestibular tests between individuals diagnosed with Parkinson’s Disease (PD) and elderly healthy controls. With consideration for potential…
- « Previous Page
- 1
- …
- 13
- 14
- 15
- 16
- 17
- …
- 181
- Next Page »